Display options
Cite
Pasman JA, Verweij KJH, Gerring Z, et al. Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability. Nat Neurosci. 2019;22(7):1196doi: 10.1038/s41593-019-0402-7.
Pasman, J. A., Verweij, K. J. H., Gerring, Z., Stringer, S., Sanchez-Roige, S., Treur, J. L., Abdellaoui, A., Nivard, M. G., Baselmans, B. M. L., Ong, J. S., Ip, H. F., van der Zee, M. D., Bartels, M., Day, F. R., Fontanillas, P., Elson, S. L., de Wit, H., Davis, L. K., MacKillop, J., Derringer, J. L., Branje, S. J. T., Hartman, C. A., Heath, A. C., van Lier, P. A. C., Madden, P. A. F., Mägi, R., Meeus, W., Montgomery, G. W., Oldehinkel, A. J., Pausova, Z., Ramos-Quiroga, J. A., Paus, T., Ribases, M., Kaprio, J., Boks, M. P. M., Bell, J. T., Spector, T. D., Gelernter, J., Boomsma, D. I., Martin, N. G., MacGregor, S., Perry, J. R. B., Palmer, A. A., Posthuma, D., Munafò, M. R., Gillespie, N. A., Derks, E. M., & Vink, J. M. (2019). Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability. Nature neuroscience, 22(7), 1196. https://doi.org/10.1038/s41593-019-0402-7
Pasman, Joëlle A, et al. "Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability." Nature neuroscience vol. 22,7 (2019): 1196. doi: https://doi.org/10.1038/s41593-019-0402-7
Pasman JA, Verweij KJH, Gerring Z, Stringer S, Sanchez-Roige S, Treur JL, Abdellaoui A, Nivard MG, Baselmans BML, Ong JS, Ip HF, van der Zee MD, Bartels M, Day FR, Fontanillas P, Elson SL, de Wit H, Davis LK, MacKillop J, Derringer JL, Branje SJT, Hartman CA, Heath AC, van Lier PAC, Madden PAF, Mägi R, Meeus W, Montgomery GW, Oldehinkel AJ, Pausova Z, Ramos-Quiroga JA, Paus T, Ribases M, Kaprio J, Boks MPM, Bell JT, Spector TD, Gelernter J, Boomsma DI, Martin NG, MacGregor S, Perry JRB, Palmer AA, Posthuma D, Munafò MR, Gillespie NA, Derks EM, Vink JM. Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability. Nat Neurosci. 2019 Jul;22(7):1196. doi: 10.1038/s41593-019-0402-7. PMID: 31168101.
Copy Download .nbib Format: NLM
Share it on

Nat Neurosci. 2019 Jul;22(7):1196. doi: 10.1038/s41593-019-0402-7.

Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability.

Nature neuroscience

Joëlle A Pasman, Karin J H Verweij, Zachary Gerring, Sven Stringer, Sandra Sanchez-Roige, Jorien L Treur, Abdel Abdellaoui, Michel G Nivard, Bart M L Baselmans, Jue-Sheng Ong, Hill F Ip, Matthijs D van der Zee, Meike Bartels, Felix R Day, Pierre Fontanillas, Sarah L Elson, Harriet de Wit, Lea K Davis, James MacKillop, Jaime L Derringer, Susan J T Branje, Catharina A Hartman, Andrew C Heath, Pol A C van Lier, Pamela A F Madden, Reedik Mägi, Wim Meeus, Grant W Montgomery, A J Oldehinkel, Zdenka Pausova, Josep A Ramos-Quiroga, Tomas Paus, Marta Ribases, Jaakko Kaprio, Marco P M Boks, Jordana T Bell, Tim D Spector, Joel Gelernter, Dorret I Boomsma, Nicholas G Martin, Stuart MacGregor, John R B Perry, Abraham A Palmer, Danielle Posthuma, Marcus R Munafò, Nathan A Gillespie, Eske M Derks, Jacqueline M Vink

Affiliations

  1. Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
  2. Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam, The Netherlands.
  3. Genetic Epidemiology, Statistical Genetics, and Translational Neurogenomics Laboratories, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  4. Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  5. Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
  6. MRC Integrative Epidemiology Unit (IEU), University of Bristol, Bristol, UK.
  7. Department of Biological Psychology/Netherlands Twin Register, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  8. MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, UK.
  9. 23andMe, Inc., Mountain View, CA, USA.
  10. Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.
  11. Vanderbilt Genetics Institute; Division of Genetic Medicine, Department of Medicine, Vanderbilt University, Nashville, TN, USA.
  12. Peter Boris Centre for Addictions Research and Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University/St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
  13. Department of Psychology, University of Illinois Urbana-Champaign, Champaign, IL, USA.
  14. Department of Youth and Family, Utrecht University, Utrecht, the Netherlands.
  15. Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  16. Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
  17. Department of Developmental Psychology and EMGO Institute for Health and Care Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  18. Estonian Genome Center, University of Tartu, Tartu, Estonia.
  19. Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
  20. Hospital for Sick Children, Toronto, Ontario, Canada.
  21. Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  22. Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  23. Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Barcelona, Spain.
  24. Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  25. Rotman Research Institute, Baycrest, Toronto, Ontario, Canada.
  26. Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  27. Institute for Molecular Medicine Finland FIMM, HiLIFE Unit, University of Helsinki, Helsinki, Finland.
  28. Brain Center Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands.
  29. Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.
  30. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  31. Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA.
  32. UK Centre for Tobacco and Alcohol Studies and School of Experimental Psychology, University of Bristol, Bristol, UK.
  33. Department of Psychiatry, Virginia Institute for Psychiatric and Behavior Genetics, Virginia Commonwealth University, Richmond, VA, USA.
  34. Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands. [email protected].

PMID: 31168101 DOI: 10.1038/s41593-019-0402-7

Abstract

Several occurrences of the word 'schizophrenia' have been re-worded as 'liability to schizophrenia' or 'schizophrenia risk', including in the title, which should have been "GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability," as well as in Supplementary Figures 1-10 and Supplementary Tables 7-10, to more accurately reflect the findings of the work.

Publication Types

Grant support